Table 2.
Summary of the main results of the study group.
| Before-O3T median (Q1–Q3) | After-O3T median (Q1–Q3) | p-value | |
|---|---|---|---|
| HADS-A (from 0 to 21) | 6.5 (3–10.8) | 3.5 (2–6.8) | 0.003 |
| HADS-D (from 0 to 21) | 4 (1.3–9) | 3.5 (0.3–5) | 0.022 |
| EQ-5D-5L: Anxiety/depression (from 1 to 5) | 1.5 (1–3) | 1 (1–2) | 0.047 |
| EQ-5D-5L: EQ VAS (from 0 to 100) | 52.5 (43–78) | 75 (60–90) | 0.015 |
| Before-O3T Correlations (rho) | After-O3T Correlations (rho) | p-value before/after | |
|---|---|---|---|
| HADS-A-EQ-5D-5L Anxiety/Depression-EQ-5D-5L, EQ VAS | 0.866, –0.554 | 0.874, –0.627 | < 0.001/< 0.001 0.026/0.009 |
| HADS-D-EQ-5D-5L Anxiety/Depression-EQ-5D-5L, EQ VAS | 0.852, –0.644 | 0.673, –0.812 | < 0.001/0.004 0.007/<0.001 |
O3T, ozone therapy; Q1–Q3: quartiles 1 and 3; HADS, Hospital Anxiety and Depression Scale; HADS-A, HADS-Anxiety; HADS-D, HADS-Depression; EQ VAS, EQ-5D-5L Visual Analog Scale self-perceived general health status.